Literature DB >> 8606351

The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitiser.

C E Millson1, M Wilson, A J Macrobert, J Bedwell, S G Bown.   

Abstract

Helicobacter pylori is associated with various gastrointestinal disorders. Lethal photosensitisation was investigated as a possible technique for killing H. pylori which might offer a better alternative to antibiotics. The susceptibility of H. pylori to lethal photosensitisation was determined by mixing suspensions of H. pylori with various photosensitisers and plating out on blood agar before irradiation with low-power laser light. Five sensitisers were studied further by mixing them with H. pylori in a tissue-culture plate and counting survivors after irradiation as a function of laser exposure time, dye concentration and pre-irradiation time. Crystal violet and thionine were ineffective as sensitisers, but zones of inhibition appeared with methylene blue (MB), protoporphyrin IX (PPIX), haematoporphyrin derivative (HPD), toluidine blue O (TBO) and disulphonated aluminium phthalocyanine (S2). Laser light or sensitiser alone did not affect bacterial viability. S2 (100 microg/ml) with a laser light energy density of 16 J/cm2, HPD (10O microg/ml) with 160 J/cm2, MB (100 microg/ml) with 21 J/cm2, PPIX (150 microg/ml) with 320 J/cm2 and TBO (50 microg/ml) with 160 J/cm2 all reduced bacterial viability by >99%. The killing of sensitised H. pylori by laser light offers a new approach to the treatment of localised infections when all colonised areas are accessible to light.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606351     DOI: 10.1099/00222615-44-4-245

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Photomechanical drug delivery into bacterial biofilms.

Authors:  N S Soukos; S S Socransky; S E Mulholland; S Lee; A G Doukas
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria.

Authors:  Faten Gad; Touqir Zahra; Tayyaba Hasan; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Bioluminescent genetically transformed bacteria as a new effective tool for testing photosensitization activity.

Authors:  M G Strakhovskaya; A P Zarubina; V G Zhukhovitskii; A F Mironov; A B Rubin
Journal:  Dokl Biochem Biophys       Date:  2004 May-Jun       Impact factor: 0.788

5.  Photodynamic therapy in gastroenterology.

Authors:  S G Bown; C E Millson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

6.  Helicobacter pylori in patients can be killed by visible light.

Authors:  Robert A Ganz; Jennifer Viveiros; Aamir Ahmad; Atosa Ahmadi; Ayesha Khalil; M Joshua Tolkoff; Norman S Nishioka; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2005-04       Impact factor: 4.025

7.  Safety assessment of oral photodynamic therapy in rats.

Authors:  Carla R Fontana; Mark A Lerman; Niraj Patel; Clovis Grecco; Carlos A de Souza Costa; Mansoor M Amiji; Vanderlei S Bagnato; Nikolaos S Soukos
Journal:  Lasers Med Sci       Date:  2012-03-31       Impact factor: 3.161

8.  Targeted antimicrobial photochemotherapy.

Authors:  N S Soukos; L A Ximenez-Fyvie; M R Hamblin; S S Socransky; T Hasan
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

9.  Antimicrobial photodynamic therapy: An overview.

Authors:  S Rajesh; Elizabeth Koshi; Koshi Philip; Aparna Mohan
Journal:  J Indian Soc Periodontol       Date:  2011-10

Review 10.  Crossed and linked histories of tetrapyrrolic macrocycles and their use for engineering pores within sol-gel matrices.

Authors:  Miguel A García-Sánchez; Fernando Rojas-González; E Carmina Menchaca-Campos; Salvador R Tello-Solís; R Iris Y Quiroz-Segoviano; Luis A Diaz-Alejo; Eduardo Salas-Bañales; Antonio Campero
Journal:  Molecules       Date:  2013-01-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.